Literature DB >> 20574807

Complex role of the HIF system in cardiovascular biology.

Gabor Czibik1.   

Abstract

The hypoxia-inducible factor (HIF) system was discovered as an oxygen-sensitive regulatory pathway that confers adaptive responses to hypoxia. Novel aspects of this growing network indicate that there is a significant, nonhypoxic contribution to regulation. Multiple lines of evidence suggest that components of the HIF pathway are intimately involved in the pathogenesis of cardiovascular disorders. This review highlights the functional context of the HIF system in cardiovascular pathobiology with possible therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574807     DOI: 10.1007/s00109-010-0646-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  115 in total

1.  Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.

Authors:  Masakuni Kido; Lingling Du; Christopher C Sullivan; Xiaodong Li; Reena Deutsch; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

2.  Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system.

Authors:  Daniel P Stiehl; Renato Wirthner; Jens Köditz; Patrick Spielmann; Gieri Camenisch; Roland H Wenger
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

Review 3.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

4.  The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction.

Authors:  R Bolli; B S Patel; W X Zhu; P G O'Neill; C J Hartley; M L Charlat; R Roberts
Journal:  Am J Physiol       Date:  1987-12

5.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

6.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization.

Authors:  Ye V Liu; Maimon E Hubbi; Fan Pan; Karin R McDonald; Malini Mansharamani; Robert N Cole; Jun O Liu; Gregg L Semenza
Journal:  J Biol Chem       Date:  2007-10-26       Impact factor: 5.157

8.  Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function.

Authors:  Jaya Krishnan; Preeti Ahuja; Sereina Bodenmann; Don Knapik; Evelyne Perriard; Wilhelm Krek; Jean-Claude Perriard
Journal:  Circ Res       Date:  2008-10-10       Impact factor: 17.367

Review 9.  ROS signaling in systemic and cellular responses to chronic intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar; Jayasri Nanduri; Gregg L Semenza
Journal:  Antioxid Redox Signal       Date:  2007-09       Impact factor: 8.401

10.  Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).

Authors:  Matthew E Cockman; David E Lancaster; Ineke P Stolze; Kirsty S Hewitson; Michael A McDonough; Mathew L Coleman; Charlotte H Coles; Xiaohong Yu; Ronald T Hay; Steven C Ley; Christopher W Pugh; Neil J Oldham; Norma Masson; Christopher J Schofield; Peter J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

View more
  6 in total

Review 1.  Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.

Authors:  Rosamaria Lappano; Damiano Rigiracciolo; Paola De Marco; Silvia Avino; Anna Rita Cappello; Camillo Rosano; Marcello Maggiolini; Ernestina Marianna De Francesco
Journal:  AAPS J       Date:  2016-02-10       Impact factor: 4.009

Review 2.  Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.

Authors:  Erwin G Van Meir; Binghe Wang; Sarah K Burroughs; Stefan Kaluz; Danzhu Wang; Ke Wang
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

3.  GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts.

Authors:  Ernestina Marianna De Francesco; Tommaso Angelone; Teresa Pasqua; Marco Pupo; Maria Carmela Cerra; Marcello Maggiolini
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

4.  Hypoxia inducible factor-1alpha mediates protection of DL-3-n-butylphthalide in brain microvascular endothelial cells against oxygen glucose deprivation-induced injury.

Authors:  Weihong Yang; Ling Li; Ruxun Huang; Zhong Pei; Songjie Liao; Jinsheng Zeng
Journal:  Neural Regen Res       Date:  2012-04-25       Impact factor: 5.135

5.  Acute Methylmercury Exposure and the Hypoxia-Inducible Factor-1α Signaling Pathway under Normoxic Conditions in the Rat Brain and Astrocytes in Vitro.

Authors:  Jie Chang; Bobo Yang; Yun Zhou; Changsheng Yin; Tingting Liu; Hai Qian; Guangwei Xing; Suhua Wang; Fang Li; Yubin Zhang; Da Chen; Michael Aschner; Rongzhu Lu
Journal:  Environ Health Perspect       Date:  2019-12-18       Impact factor: 9.031

6.  Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA.

Authors:  Sitong Ming; Mo Kan; Liu Liu; Zhuang Zhang; Xiaoran Liu; Yaxin Liu; Zhen Li; Yanhong Zhang; Qihang Pang; Jianan Lin; Hui Li; Qing Yang; Xin Sui; Xiaobo Qu; Na Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-07       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.